We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-1.37%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.2B
AUM Growth
+$2.05B
Cap. Flow
+$2.63B
Cap. Flow %
18.56%
Top 10 Hldgs %
24.41%
Holding
915
New
139
Increased
425
Reduced
186
Closed
46

Sector Composition

Rank Sector Weight
1 Healthcare 31.77%
2 Technology 24.47%
3 Financials 9.64%
4 Consumer Discretionary 7.95%
5 Industrials 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NWL icon
176
Newell Brands
NWL
$2.2B
$18.4M 0.13%
1,325,741
+1,262,781
+2,006% +$23.6M
DLTR icon
177
Dollar Tree
DLTR
$24.1B
$18M 0.13%
132,406
+24,886
+23% +$3.87M
POWI icon
178
Power Integrations
POWI
$3.53B
$17.7M 0.13%
275,895
CTAS icon
179
Cintas
CTAS
$84.4B
$17.6M 0.12%
181,392
+84,264
+87% +$8.6M
CMA
180
DELISTED
Comerica
CMA
$17.6M 0.12%
247,547
+132,235
+115% +$10.4M
OI icon
181
O-I Glass
OI
$1.41B
$17.3M 0.12%
+1,334,768
New +$18.1M
COGT icon
182
Cogent Biosciences
COGT
$6.91B
$17.2M 0.12%
1,151,502
-99,387
-8% -$1.36M
NFLX icon
183
Netflix
NFLX
$293B
$17.1M 0.12%
727,910
+389,210
+115% +$8.65M
KDNY
184
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$17.1M 0.12%
871,155
BPMC
185
DELISTED
Blueprint Medicines
BPMC
$17M 0.12%
258,311
+1,139
+0.4% +$73.2K
BSX icon
186
Boston Scientific
BSX
$67.6B
$17M 0.12%
439,336
+217,121
+98% +$8.71M
MRSN
187
DELISTED
Mersana Therapeutics
MRSN
$16.9M 0.12%
99,914
+20,292
+25% +$3.3M
IPG
188
DELISTED
Interpublic Group of Companies
IPG
$16.7M 0.12%
651,788
-216,515
-25% -$6.14M
MSCI icon
189
MSCI
MSCI
$41.5B
$16.4M 0.12%
38,919
+33,247
+586% +$15.2M
RNR icon
190
RenaissanceRe
RNR
$13.7B
$16.4M 0.12%
116,780
+73,898
+172% +$10.3M
BDX icon
191
Becton Dickinson
BDX
$43.8B
$16.3M 0.12%
73,334
+24,257
+49% +$6.04M
ECL icon
192
Ecolab
ECL
$76.4B
$16.3M 0.12%
113,112
+33,944
+43% +$5.51M
CI icon
193
Cigna
CI
$77B
$16.2M 0.11%
58,317
+26,833
+85% +$7.55M
BMO icon
194
Bank of Montreal
BMO
$125B
$16.1M 0.11%
183,029
+54,084
+42% +$5.23M
IOVA icon
195
Iovance Biotherapeutics
IOVA
$2.19B
$16M 0.11%
1,668,920
+40,000
+2% +$461K
DG icon
196
Dollar General
DG
$27.2B
$15.8M 0.11%
65,763
+19,001
+41% +$4.69M
TMUS icon
197
T-Mobile US
TMUS
$190B
$15.5M 0.11%
115,254
+16,188
+16% +$2.27M
AMT icon
198
American Tower
AMT
$77.7B
$15.3M 0.11%
71,357
+38,427
+117% +$9.87M
AMRC icon
199
Ameresco
AMRC
$1.12B
$15.3M 0.11%
230,288
ORA icon
200
Ormat Technologies
ORA
$6.28B
$15.3M 0.11%
+177,113
New +$15.8M

Similar funds

Candriam SCA's Q3 2022 Portfolio in Review

As of Q3 2022, Candriam SCA held 915 positions worth $14.2B, up 17% from $12.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA deployed $2.63B of net new capital in Q3 2022, opening 139 new positions and adding to 425 existing holdings. Its largest new stake was Veru: 378,115 shares worth $43.6M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 34% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Sociedad Química y Minera de Chile, an estimated $60.4M trimmed.

  • Candriam SCA's largest Q3 2022 buy was Veru: 378,115 shares worth $43.6M.
  • Candriam SCA added most to Apple in Q3 2022, an estimated $226M increase.
  • Candriam SCA's biggest Q3 2022 reduction was Sociedad Química y Minera de Chile, cutting an estimated $60.4M.
  • Candriam SCA fully exited Turning Point Therapeutics, Inc. Common Stock in Q3 2022, selling an estimated $36.9M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.2B portfolio in Q3 2022.
  • Candriam SCA opened 139 new positions and closed 46 in Q3 2022.
  • Candriam SCA's portfolio value rose 17% quarter-over-quarter to $14.2B.

Based on Candriam SCA's 13F filing for Q3 2022, filed 10 Nov 2022.